Chang and co-workers reported that overexpression of GRP78/p-PERK signaling pathway activates nuclear factor-erythroid 2-related factor (NRF2), leading to enhanced expression of glycolytic enzymes and stemness markers in head and neck squamous cell carcinoma, thus, supporting Warburg phenotype and cancer cell stemness (200). Here, NFE2L2 is linked to cancer.